Wednesday, 14 August 2019

AstraZeneca scores win in race to treat ovarian cancer

AstraZeneca has made further headway in the race with larger competitor GlaxoSmithKline's to use a promising new class of drugs to treat ovarian cancer.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)